• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR INC. NC TREK NEO¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR INC. NC TREK NEO¿; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 1400450-08
Medical Device Problem Codes Difficult to Remove (1528); Material Separation (1562); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/21/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure was performed to treat a lesion in the right coronary artery.After a non-abbott guidewire (gw) was advanced to the target lesion, a 4.5x8mm nc trek neo balloon dilatation catheter (bdc) was attempted to be advanced onto the non-abbott gw; however, resistance with the gw was noted and the bdc was removed before entering the anatomy.During removal resistance was felt and the tip of the bdc was noted to separate, and was simply removed.A same sized nc trek neo was used and the procedure was completed.There were no reported adverse patient effects nor clinically significant delay.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
Visual inspection, functional testing and dimensional analysis were performed on the returned device.The reported difficulty advancing and removing the bdc over the guide wire could not be confirmed; however, the reported tip separation was confirmed.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.Based on the reported information and the observations from the returned device analysis, a definitive cause for the reported difficulty advancing and removing the bdc over the guide wire could not be determined; however, the reported tip separation appears to be related to operational context.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NC TREK NEO¿
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
ABBOTT VASCULAR INC.
3200 lakeside drive
santa clara CA 95054 2807
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key20930499
Report Number2024168-2024-14736
Device Sequence Number5294341
Product Code LOX
UDI-Device Identifier08717648232749
UDI-Public(01)08717648232749(17)270731(10)40807G1
Combination Product (Y/N)N
Initial Reporter StateKY
Initial Reporter CountryUS
PMA/510(K) Number
K220634
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/17/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number1400450-08
Device Catalogue Number1400450-08
Device Lot Number40807G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 11/21/2024
Supplement Date Received by Manufacturer01/06/2025
Initial Report FDA Received Date12/13/2024
Supplement Report FDA Received Date01/17/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/07/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
GUIDEWIRE: TERUMO RUNTHROUGH
Patient Age67 YR
Patient SexFemale
Patient Weight67 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-